Review Policy

Acta Pharma Reports Journal uses double-blind review, in which the identity of both the reviewer and the author are unknown to each other. This ensures impartiality and helps every paper get an unbiased review.
Model of Double Blind Peer Review

TIMING – Pre-Prints

IDENTIFIABILITY – Double blind

MEDIATION – Editors mediate all Reviewers interactions between reviewers and authors

PUBLICATION – Peer reviews are not published

FACILITATION – Review facilitated by a journal

OWNERSHIP – Review owned by a journal or third party

Source: COPE Ethical Guidelines for Peer Reviewers